Evidence map›Paper›PMID 42718517›Full record

ArticleFrontiers in immunology2026

Micro- and nanoplastics remodel the autophagy-lysosomal axis and mitochondrial function in primary human monocytes.

Stefania Pezzana, Martina Broggiato, Fiona Limanaqi, Elena Vezzoli, Silvia Zecchini, Luigia Valsecchi, Claudia Vanetti, Lara De Luca, Clara De Palma, Michela Bardini and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefania PezzanaDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Martina BroggiatoDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Fiona LimanaqiDepartment of Biomedical and Clinical Sciences, "L. Sacco" Hospital, University of Milan, Milan, Italy.
Elena VezzoliAdvanced Light and Electron Microscopy BioImaging Centre (ALEMBIC), Università Vita-Salute San Raffaele, Milan, Italy.
Silvia ZecchiniDepartment of Biomedical and Clinical Sciences, "L. Sacco" Hospital, University of Milan, Milan, Italy.
Luigia ValsecchiTettamanti Center, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Gerardo dei Tintori, Monza, Italy.
Claudia VanettiDepartment of Biomedical and Clinical Sciences, "L. Sacco" Hospital, University of Milan, Milan, Italy.
Lara De LucaDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Clara De PalmaDepartment of Medical Biotechnology and Translational Medicine (BioMeTra), University of Milan, Milan, Italy.
Michela BardiniTettamanti Center, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Gerardo dei Tintori, Monza, Italy.
Claudio FeniziaDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Micro- and nanoplastics (MNPs) are increasingly detected in human tissues, raising concerns regarding their potential impact on immune cell function. Monocytes are among the first immune cells to encounter and internalize these particles. However, the intracellular mechanisms triggered by MNPs exposure remain poorly understood. Methods: Primary human monocytes were exposed to 25µg/mL of polystyrene (PS) MNPs ranging from 0.5 to 5 µm. Particle uptake and intracellular trafficking were investigated by transmission electron microscopy (TEM), while autophagy-lysosomal and mitochondrial responses were assessed by Western blotting, quantitative PCR, ultrastructural analyses, and metabolic flux measurements. Results: Ultrastructural TEM analysis revealed that primary human monocytes internalize MNPs through phagocytosis, followed by phagosome maturation and fusion with lysosomes. At a molecular level, MNPs exposure is associated with marked remodeling of the autophagy-lysosomal system, characterized by increased lysosomal abundance, elevated LC3-II/I ratio, and accumulation of autophagy-related vesicular structures. Although p62 protein levels increased following exposure, no corresponding changes were observed at the transcriptional level for key autophagy-associated genes, suggesting predominantly post-transcriptional regulation of these pathways. MNPs exposure also altered mitochondrial organization, increasing mitochondrial number while reducing mitochondrial area. Consistently, expression of the mitophagy-related gene Conclusions: To our knowledge, this study provides the first integrated, size-resolved characterization of MNPs uptake and intracellular responses in primary human monocytes, combining ultrastructural and biological evidence of phagocytic internalization, autophagy-lysosomal flux, mitochondrial homeostasis, and cellular bioenergetics within the same experimental framework. MNPs uptake was associated with concurrent alterations in the autophagy-lysosomal axis, mitochondrial homeostasis, and cellular metabolism. Our findings further provide evidence that exposure to MNPs at 25µg/mL affects key intracellular pathways involved in immune cell homeostasis. These results highlight a potential link between particle accumulation and cellular alterations, which may have implications for myeloid cell function and long-term health.

Indexed as

AutophagyLysosomesMitochondriaMonocytesPolystyrenesCells, CulturedHumansPhagocytosisPolystyrenesautophagy-lysosomal systemhuman healthimmune systeminternalization pathwaymicroplasticsmitochondriaprimary human monocytesultrastructure

Identifiers

PMID42718517
PMCPMC13553408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.